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1.  Summary 
Key questions for this project were: How is genetic knowledge affecting policy and practice in 
perinatal health care services? What challenges and opportunities does the knowledge present, 
and how do practitioners address these in their daily work, both individually and together? What 
aims and values guide them, and how can insights from ethics and social science help? How can 
these insights be shared in more useful ways with busy practitioners? Can multidisciplinary group 
discussions help staff to discuss and resolve dilemmas?  
 
Participants and data collection  Seventy people working in or linked to two English hospitals, 
(one teaching hospital and one district general hospital) and in attached community services, 
were interviewed individually by the two research sociologists (PA and CW). The 
semi-structured 'guided conversations' encouraged  respondents to give their own accounts and 
meanings. The interview themes included interviewees' views about genetic developments and  
moral beliefs and values, and how these affected their daily work. Interviews were supplemented 
with ethnographic observations. Fifty-six  interviewees then took part in eleven small discussion 
groups led by a health care ethicist (BF); twelve people attended twice, at their request. Their 
work related directly or indirectly to perinatal care, and participants included: midwives; health 
visitors; neonatal nurses; genetic counsellors; sonographers; obstetricians; fetal medicine 
specialists; haematologists; paediatricians; psychologists; chaplains; legal, audit and primary care 
managers. For approximately two hours each, the groups discussed topics raised during the 
earlier interviews, and were of mixed disciplines and seniority. With permission, interviews and 
seminars were taped and transcribed. Participants gave short follow up individual evaluations of 
the seminars.   
 
Data analysis   The transcripts were analysed and coded by content for emergent themes. Codes 
were compared for similarities and differences across the groups, eventually leading to broader 
themes which made up the overall theoretical framework. The research team met frequently to 
discuss the data and analysis and to incorporate sociological and philosophical perspectives, in 
order to add to the richness and validity of the analysis. 
 
Results of the intervention Participants found the in-hospital 
ethics seminars useful in increasing inter-professional 
understanding, engaging people from varied backgrounds, covering 
a wide range of pressing issues coherently, and addressing 
important though seldom discussed ethical questions. Crucially, 
the agenda were based on prior in-depth interviews with health 
staff on their key, local concerns about the social and ethical 
consequences of advances in genetics and their impact on 
professional policies and practice. The seminars worked well in 
contrasting hospitals and specialties. A planned series of 
seminars would have more effect on policy and practice than 
single events and could, potentially, contribute usefully to 
clinical governance.  
 
Reports  The main outcomes of the project are papers for professional and academic journals 
based on the transcripts. The papers completed so far, report: participants’ evaluations of the in-
hospital ethics seminars; the many complications which practitioners experience when trying to 
provide equitable prenatal services linked to the characteristics of the women they work with and 
to broader questions of ethnicity, gender and religious belief; the complications of trying to ` draw 
the line’ over which fetal conditions should be tested and referred for termination of pregnancy; 
the dilemmas raised by nuchal translucency utlrasound scans; and whether non-directiveness and 
informed choice are possible in the context of antenatal screening and testing.  
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2.  Background  
 
By the mid to late 1990s, reports in the mess media, and the scientific, medical and ethics press 
could be taken to assume that genetics was flourishing in medical practice as a regular basis for 
clinical diagnosis and prognosis, and for understanding the aetiology and progress of disease (ref. 
1). During our research project 1999-2001, genetics-linked news was seldom out of the headlines. 
[See Tables 1-3] Official expectations of the developments were high. 
The expert report The genetics of common diseases stated: 
  
`Many of the most important human disease genes are likely to 
be identified within the next five years....It would be easy 
to underestimate the impact this is likely to have on the 
definition and understanding of disease and in turn its impact 
on health care. We face quantum changes in understanding akin 
to the changes in the knowledge of infectious diseases that 
accompanied the microbiological revolution started by Pasteur 
and Koch....these developments present dramatic new 
opportunities to improve the health of the nation’ (Department 
of Health 1995). 
 
During our research interviews and seminars, practitioners often 
mentioned news items related to genetics. A health visitor said: 
 
`When I talked about the [ethics seminar] group to my husband, 
he’s a chemist, he reminded me that a few years ago I used to 
say [about media reports of scientific innovations] “that’ll 
never happen” but he knew it would happen and he was right. 
Since the meeting I’ve seen things in the [news]papers and 
thought....perhaps it will happen here one day. I’m worried 
about how some people are over-treated.’  
 
The brief summary in tables 1-3 mentions only a few of the 
relevant events. There were also growing numbers of related 
research projects, publications, multi-disciplinary conferences 
and policy meetings with associated briefing papers and lobbying 
during this period, besides art exhibitions, such as, `Paradise 
Now: Picturing the Genetic Revolution’ and `Artists Mine Genomic 
Issues: Unnatural Science’ both in New York, 2000.   
 
Tables 1-3 The international context of developments in genetics 
around the millennium 
 
Abbreviations: 
AAAS American Association for the Advancement of Science 
ACGT Advisory Committee on Genetic Testing (UK) 
BMA British Medical Association 
EGE European Group on Ethics in Science and New Technologies, advisory group 
to European Commission. 
FDA US Food and Drugs Administration 
GM genetically modified 
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HFEA   Human Fertilisation and Embryology Authority (UK) 
HGC Human Genetics Commission (UK) 
HTA Health Technology Assessment, Southampton publishes systematic overviews 
and policy reports.  
NHGRI National Human Genome Research Institute (US) 
RCOG Royal College of Obstetrics and Gynaecology 
WMA World Medical Association 
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Table 1. 1999 
 
 
1999 
April 
 
 
 
May 
 
Nuffield Council on Bioethics publishes positive report on 
genetically modified food. Critical reviews illustrate 
growth of media and public hostility towards GM foods.   
 
June 
 
 
 
July 
 
IVF specialist, Dr Edwards announces `soon it will be a 
sin for parents to have a child that carries the heavy 
burden of genetic disease’.Publicity about using stem 
cells to grow replacement organs. Gene linked to Alzheimer 
identified. UK government bans human reproductive cloning 
and sets up advisory group to consider `therapeutic’ 
cloning. 
 
Augus
t 
 
Cystic Fibrosis Trust Director gives conference lecture 
`Why GM Humans are a Good Idea’. Indian government asks 
doctors to stop providing prenatal sex selection services. 
 
Sept 
 
Jesse Gelsinger dies during US genetic trial. Ovarian 
tissue is transplanted back into a woman in UK. Prof 
Sheila McLean (Glasgow) calls for national bioethics 
council to considered such cases. Conference at the Galton 
Institute about eugenics is disrupted by protestors. Craig 
Venter develops blueprint to construct a synthetic 
bacterium. An ectopic triplet survives to be delivered 
safely with his sisters at 29 weeks. `Genius’ gene NR2B 
manipulated in mice at Princeton. Public debates about 
insurers’ rights to use genetic tests.   
 
Oct 
 
Chromos Molecular Systems, British Columbia, announce they 
have bred mice which inherit their parents’ artificially 
inserted chromosomes. Stock and Campbell argue that 
artificial chromosomes may offer better gene therapy in 
humans than viral vectors.  New Scientist (1023) leader on 
benefit and inevitability of genetically modified embryos. 
BMA supports human reproductive cloning. 
 
Nov 
 
HFEA and ACGT publish consultation document on 
Preimplantation Genetic Diagnosis. Transplanted fetal 
cells appear to benefit a patient with Parkinson’s.  
 
Dec 
 
US Hudson Institute hosts international meeting on dangers 
of the future biological arms race; genetics could quickly 
make Chinese race the most powerful one and opting out of 
biological race is said to be as dangerous as opting out 
of nuclear arms race.    
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Table 2.  2000 
 
2000 
Janua
ry 
 
Icelandic parliament grants US DeCode company exclusive 
license to genetic database of 270,000 population for 12 
years - after DeCode gave large donations to the political 
parties.  Lord Winston’s lecture to Royal Society 
expresses his distress at being unable to use therapeutic 
cloning. UK NHS receives first royalties bill from US 
biotech company for using tests to identify a breast 
cancer gene. RCOG asserts that only two embryos should be 
implanted after IVF. FDA temporarily put gene therapy 
experiments on `clinical hold’. 
 
Feb 
 
UK Government’s ACGT, subsumed into the new Human Genetics 
Commission HGC, publishes report for consultation on 
Prenatal Genetic Testing. US Asilomar 2 symposium of 
leading academics and politicians debates self-regulation 
by geneticists. European Parliament withdraws patent for 
human cloning after protests. HFEA permits frozen eggs t 
be implanted.  UK government consider setting up a large 
national DNA data base. 
 
March 
 
Biotechnology Industry Organisation BIO conference, and 
alongside a large protest Biodevastation conference, in 
Boston. British Council of disabled People issue a 
Position Statement and List of demands on Disability and 
the New Genetics because of their alarm about genetic 
developments. Berkeley researchers announce first `bionic 
chip’ part living tissue part machine for potential 
implants to treat disease such as diabetes. UK government 
seem to retract on former open enthusiasm for GM food. 
 
April 
 
BBC Radio 4's annual Reith lectures, this year on Respect 
for the Earth, with much support for biodiversity and 
criticism of GM agriculture, again reflects public concern 
about GM animals, crops and food but little interest in GM 
humans. BMJ publishes article on how genetics `will 
transform performance in the health services’ and 
`education of all health care professionals [is] needed in 
order to capitalise on the results of genomics research’. 
`obesity gene’ found in mice.  
 
May 
 
HGC’s first public consultation meeting. Publicity scare 
over 150 Sheffield women given false positives when 
screened for Down’s syndrome. Fluorescent `labelling’ of 
genes developed in Massachusetts. HTA recommends expansion 
of haemoglobinopathy screening. WMA plans guidance on data 
bases, concerned about genetics, confidentiality and 
international inequalities. Tow French babies with Severe 
Combined Immuno-deficiency respond well to gene therapy.  
 
June 
 
Draft DNA Human Genome Sequence publicised in US and UK, 
accompanied by numerous media articles about genetics 
advances. Conflicts between US commercial sequencing 
(Craig Venter, Director of Celera) and UK non-profit 
sequencing (largely funded by Wellcome Trust)which opposed 
patenting.   
 
July 
 
UK Economist has 16 pages on genetic advances and 
`tailored’ children.  s Royal Society international report 
on the benefits of Transgenic Plants and World 
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Agriculture.  
 
Augus
t 
 
 
 
Sept 
 
AAAS report Human Inheritable Genetic Modifications 
reviews dangers of germline engineering but does not call 
for a ban and instead advises on future  regulation. US 
scientists are granted federal funding for human embryonic 
stem cell research. UK surveys show public opposition to 
human cloning and show that experts tend to say they 
regret that it will inevitably happen. US Hastings 
Bioethics Centre publishes a Disability Rights Critique of 
Prenatal Genetic Testing.  European Parliament votes to 
oppose human cloning. British Sociological Association 
Annual Medical Sociology Meeting has its first genetics 
`stream’; far more highly attended than the rooms booked 
could hold.   
 
Oct 
 
In the US, Mr and Mrs Nash have a son Adam who was 
selected as an embryo to be a bone marrow donor to his 
elder sister who has Fanconi’s anaemia. A Scottish couple 
seek to ensure a female embryo is implanted, after their 
daughter died. Japanese and Dutch governments ban human 
cloning. The European Patenting Office refuses a human to 
pig, cow or sheep mixed species cloning patent. The 
application said that the US company BioTransplant Inc and 
Stem Cell Sciences Australia had already produced pig-
human embryos.  
 
Nov 
 
UNESCO’s International Bioethics Committee debates ethical 
and economic aspects of human genetics in Quito. Lawsuit 
over Jesse Gelsinger who died in a genetic trial is 
settled out of court; scientists and funders allowed to 
resume research. Enquiries reveal other adverse episodes, 
regulatory violations and financial conflicts of interest 
in trial. EGE advises against embryo cloning for stem cell 
research and use. Disabled Peoples International (Europe) 
position statement on threats to their rights and survival 
from the new genetics.    
 
Dec 
 
US religious group, the Raelians, fund attempts to clone a 
dead child. US bioethicists Buchanan, Brock, Daniels, 
Wikler publish `From chance to choice’, arguing that human 
genetic engineering is inevitable and maybe desirable to 
create more just societies. UK and US scientists seek 
approval for gene transfer in utero trials which would 
affect fetal germline.  UK issues patent for `designer 
sperm’, developed through research which lies outside HFEA 
regulation. Japanese scientists grow sperm and aim to 
reprogramme male cells to produce eggs so that gay men can 
father and `mother’ children. The technique uses cloning 
but evades Japanese laws by producing gametes not embryos. 
    
 
 
 
Table 3  2001 
 
2001 
Janua
 
New US President Bush supports voluntary and temporary 
controls, and only for federally funded research on human 
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ry cloning. First GM (rhesus) monkey, ANDi, reported. British 
Parliament allows `therapeutic human cloning’. Cystic 
Fibrosis Trust, highest spending charity on single-gene 
research, closes its support network for adults with CF 
(who criticise the Trust’s use of sickly child image to 
raise research funds. 
 
Feb 
 
Human Genome Sequencing completed at total of 30-40,000 
genes. Craig Venter of Celera Genomics (US) claims that the 
main potential use will be pharmacogenetics and not genetic 
engineering. Francis Collins NHGRI (US) claims there will 
be pressure on future scientists to enhance human embryos 
genetically. HGC consultation document on Personal Genetic 
Information (on gene banks, genetic discrimination, 
insurance, personal privacy).  House of Commons Science and 
Technology Committee and Royal Society of Medicine 
criticise British Government’s line on allowing insurance 
companies to use genetic tests. Johnjoe McFadden (Essex 
University) warns that `our genes are doomed’; unless we 
resort to human GM we will fail to compete internationally. 
   
 
March 
 
Council of Europe’s protocol against human cloning takes 
effect. US Congress pre-legislation hearing on Human 
Cloning. Coalition of US organisations opposed to human 
cloning and inheritable genetic modification. Drs Antinori 
and Zavos hold workshop in Rome on cloning human beings, 
despite cross national condemnations. 
 
April 
 
Prof Robert White, neurosurgeon at Cleveland Ohio, reports 
his research on transplanting monkey heads, arguing that 
the person is the brain - which may require a new body. 
Five cloned transgenic piglets born at Roslin Institute. 
 
 
Main sources: British Medical Journal; Medical Ethics Bulletin (UK); Genetic 
Crossroads (US); Human Genetics Alert (UK), New Scientist. 
 
 
 
Against this background, our qualitative sociological and philosophical research project 
investigated how health care practitioners and managers were facing practical and ethical issues 
associated with the `new genetics’ in their daily work. We conducted interviews and group 
discussions in two hospitals. One aim of the discussions was to ` bring ethical discussions into the 
hospital’. Knowledge of bioethcs amongst health care professionals has expanded rapidly over 
the past two decades, and although in-house ethics committees which review clinical practice 
(rather than research) are still rare in Britain, ethicists work closely with practitioners in hospitals 
in London, Manchester, Oxford, Edinburgh, and other centres.  
 
Links between everyday practice and the formal application of bioethics, however, are usually 
made personally by individuals who have attended conferences or courses, or read ethics 
literature. They then face the challenge of applying ethical ideas not only to their own practice, 
but possibly also to the policies, rules, relationships, routines and resources which structure their 
work. Attempts to change practices in order to raise ethical standards bring complications and 
stress and, unsurprisingly, people who return to their department from courses with enthusiasm to 
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promote new ideas encounter difficulties and may become disillusioned. One possible solution is 
to bring ethics into the hospital by convening seminars for groups of practitioners who share in 
reviewing problems and considering changes and practical ways forward. We organised small 
group seminars chaired by a philosopher within the hospital departments involved with the 
research. 
 
`The new genetics’ 
The new genetics refers to knowledge and techniques arising out of the discovery of recombinant 
DNA in the 1970s. It involves research into the genetic components of disorders and behaviours, 
and the clinical application of genetic knowledge to testing, screening, informing and treating 
affected people. Many social and ethical issues raised by the new genetics are not new. However, 
the new genetics is associated with geneticisation in the increasing tendencies to reduce 
explanations for physical, mental and behavioural differences to possible genetic origins. The 
promotion of a model of genetic disease and medical alleviation can divert attention and 
resources away from possible social origins and social remedies for health and behavioural 
problems. The growing influence of genetics in medical practice effects slow changes in attitudes 
among individuals and society towards future generations, human identity, relationships  and 
reproduction, and towards the prevention and control of disease. (2) Hoedemaekers and Have (3) 
list six incongruities, which arose from the geneticization of prenatal services in Cyprus since 
thalassaemia began to be prevented three decades ago. These are:  
  the difficulty of promoting free choice in the directive environment of the clinic;  
  health care staff are mainly responsible for the framework of prenatal decisions yet they push 
responsibility for choice making on to prospective parents;  
  doctors promote medical methods of prevention, abortion, which go counter to accepted 
traditions of medical support, treatment and cure for the weak;  
  as induced abortion becomes less exceptional it becomes more standard, thus compromising 
practitioners’ efforts to offer equally balanced choices;  
  free individual choice is emphasised but the hidden public pressures are underestimated;  
  contrary to the usual public statements, the new diagnostic techniques serve the purposes of 
country and state.   
 
In relation to these types of concerns, we investigated how staff in the two English hospitals 
thought about the current and potential advantages and disadvantages as the expanding new 
genetics affected their work.  
 
`Genetic screening’ 
Genetic screening is widely referred to (4), although the term is largely inaccurate. The only 
Mendelian single-gene conditions screened for in Britain, and then in only a few areas which 
have `high risk’ populations, are sickle cell and thalassaemia. In contrast to genetic tests, 
ultrasound and maternal serum screening search for phenotypes such as raised hormone levels, or 
anatomical anomalies (5). Down’s syndrome and spina bifida are not Mendelian conditions so 
that antenatal staff and prospective parents are much less likely to know people living with the 
conditions which are detected by serum screening and scanning. Their discussions and decisions 
may therefore tend to be less informed, with less attention to the range of likely severity and the 
difficulty and complexity of trying to decide whether the potential life might be worth living, 
than they would be in genuine genetic screening. Significantly, the haematology staff we spoke 
with had detailed practical knowledge about these familial conditions through their daily  work 
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with all age groups and their discussions tended to pay more attention to the varied severity of the 
conditions, including mildly affected cases.  
 
Our research about genetics around the millenium has been much concerned with prenatal 
screening, for several reasons. A broad definition of screening covers the follow up tests, 
although chorionic villus sampling and amniocentesis now are used in Britain too selectively 
with high risk cases to be defined as screening, but some follow up tests check genotypes. At 
present, the widening gaps between genetic knowledge and clinicians’ ability to treat genetic 
conditions are especially apparent in the prenatal period when the main `remedy’ available is 
termination of affected pregnancies. Scanning contributes towards closing the gap between 
genetic testing of selected high risk cases and mass routine screening of healthy populations. 
Although scans cannot detect the main single gene conditions such as cystic fibrosis or 
haemaglobinopathies they open the way for genetic knowledge to be introduced rapidly into 
prenatal diagnostics in the following ways. Increasingly, women are offered nuchal translucency 
scanning for possible chromosomal conditions earlier in pregnancy (11-2 weeks) as part of their 
first routine visit to the antenatal clinic, a stage when many consider that a decision to terminate 
is not as serious and painful a decision to make as it would be later on. The women do not have 
to elect to visit especially for the scan, as they do for maternal serum screening at about 18 
weeks. When tests are offered on this opt-out rather than an opt-in basis, acceptance rates are 
much higher (Angus ref). `One-stop clinics’ which offer the tests, counselling and option of 
abortion in one visit are also liable to speed and expand the acceptance of interventions for fetal 
anomalies among all pregnant women. As new genetic knowledge and techniques, such as the 
possibility of isolating fetal cells in maternal blood, develop, the practical channels for 
implementing this knowledge will already be deeply entrenched in routine services; the new 
knowldge and skill will be able to flow rapidly into  care. The staff were however, very 
concerned that already there is not time to discuss the list of potential problems and options. 
Discussions about screening and testing revealed professional attitudes and practices which 
linked to current and potential future work with the gradual expansion of genetic diagnoses and 
treatments into the health services, and raised many relevant ethicall issues which perplexed the 
staff. 
However, we have tried to avoid using the term ` genetics screening’, except when quoting health 
staff who used the term, for these reasons. We have aimed to stand back from the expansion of 
genetics, and its actual or putative links with the new reproductive technologies, in order to 
question and examine these links critically, and not to assume that they already exist. Discussion 
of phenotypes (the expression of genes which merges into nurture and environment) as if they are 
genotypes becomes part of the uncritical process of geneticisation. Research and policy which 
assume that ` genetic screening’ is already widely implemented may also inadvertently contribute 
to the genetic expansions which we set out to examine. Before genetic screening is actually 
introduced across Britain, it would be advantageous if policy makers and the general public 
debated the costs and benefits of such a decision, instead of using terms which imply that the 
decisions had already been made. 
 
Genetic concerns in hospital practice around the millennium 
Around 2,000 AD, how closely linked, in the view of practitioners, was genetics to clinical 
practice in Britain? We planned to conduct research in preconceptual, prenatal and neonatal 
departments. A preconceptual specialist said that genetics was not sufficiently relevant to his 
work for it to be worthwhile for us to research his department. The neonatal staff took part in 
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interviews and seminars but said that genetics was of little relevance to their specialty, because 
genetics conditions were usually referred for termination of pregnancy if they were detected 
prenatally, or else the conditions, such as cystic fibrosis, sickle cell or muscular dystrophy, tend 
to present after the neonatal period. The prenatal staff were much concerned with chromosomal 
and anatomical rather than strictly Mendelian conditions, but the genetics of fetal sex was much 
discussed in one hospital. The practitioners who expressed most directly concern with Mendelian 
genetics, at preconceptual, prenatal, childhood and adult stages, were the haematology staff and 
community paediatricians caring for children with special needs.  
 
 
3.  Aims 
 
In this research about how new genetic knowledge affects health 
services policy and practice around the millenium, the main aims 
were: 
 
* to review the social and ethical consequences, of advances 
in genetics, and their impact on professional policies and 
practices in pre and post natal services;  
* to examine influences and interactions between disciplines 
with their different aims, methods, knowledge and values in 
promoting health; 
* to contribute to greater mutual understanding between 
disciplines of the opportunities and challenges brought by 
genetic advances and the means of addressing these collectively; 
* to build on the very varied expertise of the group members 
in order to develop academically sound and practical multi-agency 
ways of addressing dilemmas raised by genetic advances. 
 
The seminar participants were informed that the more detailed 
aims of the in-hospital ethics seminars were: 
 
* to have a multi-disciplinary discussion about ethics in 
relation to perinatal services and genetics which we hope will be 
useful to everyone attending; 
* to see how a visiting ethicist can assist team discussion 
within the hospital setting; 
* to begin to see whether this type of small group ethics 
discussion could be a useful format for other departments and 
hospitals to develop; 
* to contribute further data to the Cross Currents in Ethics 
and Genetics research project for use in reports about the 
research methods and findings. 
 
  The aims are partly complementary and partly conflicting. They combine holding experimental 
groups, with documenting practitioners’ views, and with possibly altering those views through 
the seminars. The aims include bringing philosophy into the hospital to take account of the local 
context, and also creating a transferable format useful to other hospitals and specialties. The 
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groups were intended to be enjoyable, stimulating and useful for people with a range of interests 
and levels of knowledge about ethics. We hoped that people would think that the groups 
deepened their thinking. How far the aims were achieved is considered in the conclusion. 
 
 
4. Methods 
 
The research was based at an inner city teaching hospital A, and 
an outer city district general hospital B. In-depth interviews 
were conducted with 69 staff in prenatal and neonatal departments 
and in related clinical, management and community services (by PA 
and CW) (see table 4 the information leaflet, table 5 the list of interviewees, and table 6 the 
interview questions and themes). Most of the interviewees later took part 
in ethics seminars facilitated by the ethicist (BF) (see table 7 information sheet, and 
table 8 list of seminar participants). We conducted some observations of the staff working in 
clinics. Both hospitals served very varied communities with many people who had African or 
Asian origins.  
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Table 4.  Information leaflet about the project (Set out in A5 folded leaflet) 
 
 
Cross currents in genetics 
a study of how staff working in perinatal services in two London Hospitals  
address questions about genetics and ethics which affect their work 
April 1999-March 2001 
 
 
Please would you help us with our research? 
We are asking 32 members of staff at your hospital 
*  to take part, over 14 months, in two interviews  
*  to take part in one two-hour small group discussion, about ethical and legal issues raised by advances in 
genetic knowledge 
*  to allow us to observe them working with their colleagues  
*  and, if appropriate to observe them working with patients 
at times to be agreed with them. 
 
We hope that people who take part in this project  
will find it personally useful to them. 
 
Researchers:  
Priscilla Alderson PhD Reader  Bobbie Farsides PhD,  
0171 612 6396,   Senior Lecturer in Medical Ethics,  p.alderson@ioe.ac.uk, 
 Centre for Medical Law and Ethics, 
Clare Williams PhD RGN HV 0171 848 2382 
Research Officer   bobbie.farsides@kcl.ac.uk 
0181 898 6728 
This leaflet gives some details about the project.  
If you are interested, we would be pleased to give you more information.   
 
 
 
 
2. 
The research questions  
*  How does new genetic knowledge affect policy and practice 
 in perinatal health care services?  
*  What challenges and opportunities does the knowledge present? 
*  How do health care staff address these in their daily work,  
individually and together?  
*  What aims and values guide them, and how can  
insights from ethics and social science help?  
*  How can such insights be shared in more useful ways  
with busy practitioners?    
*  How can small multi-disciplinary group meetings  
help staff to discuss and resolve dilemmas? 
 
Research aim   
 To work with perinatal staff to develop ways to address ethical and legal issues, raised by genetic advances, 
which help staff who inform and support patients affected by these advances.   
 
 
 
3.  Research methods   
* Talking with and observing the work of 32 staff from 16 disciplines: medicine, nursing, midwifery, 
counselling, technicians, clergy, research, administration and management 
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*  Eight 2-hour multi-disciplinary taped discussion groups, each for 4-6 staff, led by a philosopher, about 
ethical and legal issues raised by advances in genetic knowledge.  
* Over 14 months, 2 audio-taped interviews with the 32 staff, lasting 1 to 2 hours. 
* Qualitative and quantitative analysis of data, to report in journals for practitioners, policy makers, and 
medical law and ethics teachers. 
 
Risks, discomfort   
 Some staff might feel anxious about some of the topics we will discuss with them, but our aim is to help them 
to find supportive ways of tackling dilemmas.  
  This project mainly concerns the health staff, but some patients will be indirectly involved when we observe 
the staff during their daily work. If our observations appear to distress patients or staff, or to interfere with 
professional care, we will withdraw. 
 
 
 
 
4.  
Rights of all staff and patients affected by the research       
We respect your rights:  
*  to take time to decide whether to agree to help us;  
*  to refuse to take part or to be observed,  
without this affecting your work or care;  
*  to sign a consent form if you agree to help us;  
*  to refuse to answer certain questions;  
*  to withdraw from this project at any time;  
*  to have notes and tapes about you kept in a safe lockable place  
    and registered under the 1998 Data Protection Act;  
*  to be kept informed about the research and reports if you wish;  
*  to have your privacy respected,  
by making sure you cannot be identified,  
     if we repeat your comments to other people,  
and when we publish reports about the research.  
 
The project has the approval of :  
--- Hospital Research Ethics Committee 99/119 and of  
Professor ---- Consultant Obstetrician. 
 
Funder: The Wellcome Trust 
 
Heads of Department 
Professor Ann Oakley Professor Jonathan Glover 
Social Science Research Unit Centre for Medical Law and Ethics 
Institute of Education  King’s College 
University of London  University of London 
 
May 1999 
 
 
 
A similar shorter version was prepared for anyone being cared for the staff we were observing. 
 
To protect anonymity, each practitioner is identified in our publications by a number and the 
hospitals are not identified, although a similar range of views was found in each one. In addition, 
practitioner titles have been purposely kept broad, so for example, practitioners described as 
'midwives' range from junior midwives to senior managers, whilst 'obstetricians' covers research 
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fellows, specialist registrars and consultants working in obstetrics and fetal medicine.  
 
 
 
Table 6.  The interview questions and themes  
Cross currents in genetics    June 1999 
 
Name; post; time in profession; and at hospital or health district;  
previous experiences in this or other profession; main qualifications/ courses attended. 
 
1.  General account of your daily work, main duties, job description, does it have any explicit reference to 
genetics? Your views on working in or near a leading university and research hospital. Your views on how 
your work relates to/ fits-in-with colleagues in the same and in the other professions, and in the hospital 
and/or community team. The supports or pressures you experience. 
 
2.  What kinds of opportunities and challenges do genetic advances present in your work? 
(Talk about meanings of “genetic advances”. If the reply is “none”, ask prompts) 
What does `genetics’ mean to you? What words does `genetics’ bring to mind? 
Will you give one or two detailed examples of how you dealt with related practical questions recently, alone 
or with colleagues? (Prompts if needed, such as: to introduce a new type of test; to counsel prospective 
parents; to help a baby with a serious genetic condition to survive? Any changes in routines or attitudes 
among colleagues over past decade, that might have been influenced by new ideas in genetics? Who benefits? 
Patients, junior or senior staff, research, the trust, society?) How might the new genetics affect your work in 
future? (Note active and/or passive, optimistic and/or pessimistic, pragmatic and/or principled replies, 
confidence or diffidence.)  
 
3) What values and beliefs inform your thinking - ethical, legal, financial, professional, personal? (Such as 
when considering which conditions are worth screening for and why,  
or how you inform and support patients/clients, or why you value informed choice or believe it is not 
achievable.) Do you feel your colleagues share and support your values?  
Do you feel your employers share and support your values? If so, how or how not?  
Can you give examples, such as what you feel others expect or require you to do? 
Do you have formal or informal discussions or negotiations with them, or are expectations implied? Do you 
think there is general agreement among the staff, or personal or discipline differences? And how are any 
differences negotiated? 
 
4) How helpful or relevant is, or might be, some formal knowledge of ethics, law and social science (research 
methods) to you and your colleagues? Any examples, especially in understanding and dealing with the 
consequences of genetic advances? Any ethical questions, examples, experiences, you have had or heard of 
that you think it could be useful to discuss in small group? Views on ethics and teaching methods that guide 
or promote debate or work towards solutions? What would you expect or want from an ethics session? 
Might our research team be useful to you / your department in sharing in/ promoting discussion? (They may 
say they have no time and it is unnecessary. They might have ideas on themes or methods for the groups and 
later interviews, or even on social science research for the future.)   
 
5) Follow up to the interview - discussion groups. Answer any questions about these and check if interviewees 
are willing to take part. Ask if they have any questions for us.   
We might have too many people for the groups. 
Can we observe you at work?  
Do you have any suggestions of your colleagues we could approach? 
 
 
 
Table 7.  Seminar information sheet. 
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Table 8.  List of seminar participants.  
T = teaching hospital D = district general hospital 
 
[Clare - the next list got muddled and I cannot remember which col is which and which is the missing heading can 
you help? Did you have a proper version at any time? Shall I use the lists you presented to the advisory group?] 
 
Group nos. consult  managers men hours 
Present -ants     
 
T1 6 1 1  1  1 1.5  
T2 5 1 3  1  2 1.5 
T3 6 1 2  2  1 1.5 
T4 4 2 1  -  1 2 
T5 9 1 1  1  3 2 
T6 7 3 1  1  1 2 
T7 7 3 3  2  3 2 
sub 
totals 44 12 12.5 
 
D1 5/6 1 - 1?  - 2 
D2 5 2 1 2  1 2 
D3 7 - 2 1  - 2 
D4 5 - 2 1  1 2 
sub 
total 22     2 8 
 
total 66 17 17 13  14 20.5 
 
Professions;  
Teaching hospital 
Midwives: 4, managers, 3 ultrasound scanners, 1 in community, 1 in research 
Nurses; 2 NICU sisters;. 
Consultants: 2 fetal medicine; 1 obstetrician; 1 paediatrician; 2 
neonatologists; 3 haematologists;  
Registrars and research fellows: 7 obstetric/fetal medicine 
Genetics counsellors: 2 
Psychologists: 2, psychoanalyst: 1; bereavement counsellor: 1;  
Haematology scientist: 1; Chaplain: 1; Legal adviser: 1.   
43 people were interviewed, 24? Of whom attended one or two groups 
3 declined, (chaplain, psychiatrist,) 
4 couldn’t find suitable date (nurse manger, psychotherapist??, GP) 
3 left before the groups met (chaplain, lecturer, midwife) 
8 were interviewed for background breadth of ideas 
District Hospital 
21 of 26 interviewed attended a group 
3 declined (scanner, lecturer, translator) 
1 could not find suitable date (GP) 
I cancelled at last minute (chaplain)  
Midwives; 4 managers, 3 lecturers, 2 juniors, 1 community, 1 genetic 
counsellor 
Consultants: 1 obstetrician, 4 community paediatricians,  
2 clinical audit managers; 2 health visitors; 1 psychologist; 1 PCG chief 
executive. 
 
Preparation for the seminars 
Methods of organising the seminars are recorded in this background report at some length, in 
order to supplement the brief accounts in our published papers for the benefit of those who would 
like to organise similar ethics meetings. The earlier sociological interviews were an important 
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preparation in gathering relevant and timely themes to discuss at the seminars.(6) Interviews 
lasted from 45 to 120 minutes. Of the interviewees asked to take part in a research seminar; xx 
refused, xx had to drop out at the last minutes, xx attended twice at their request which we had 
not expected, and xx joined groups but had not been interviewed.  
   
While we interviewed, our plans gradually changed. We dropped from 120 to 90 minute sessions, 
in case people were deterred from attending, although after three seminars which seemed too 
short we returned  to 120 minutes and this worked well. We moved from plans to video into 
audio taping. It was important to be unobtrusive in sessions when people were asked to risk 
speaking openly. Two researchers (PA and CW) acted as observers and were able to identify 
speakers later from tapes and notes. We discussed how to balance the good research practice of 
warning people about an expected agenda, with being flexibly responsive to directions the group 
might take spontaneously. We debated the numbers of people to invite and moved up from six to 
inviting eight or more, partly to ensure a good attendance as people often had to drop out at short 
notice to respond to emergencies. The aim was to balance time for each person to speak fully 
with having enough contributors for a lively discussion. The average of seven participants 
worked well.  
   
Convening the groups was a major task (by CW) requiring numerous phone calls to arrange and 
confirm dates, and remind everyone the day before. This time investment was probably essential 
to ensure a good attendance. The easiest group to convene was the only single interest one 
(haematology). They were, however, keen to attend second groups to meet a greater 
interdisciplinary mix and more `challenging and conflicting views’. It is possible that a larger 
single issue group would have been worthwhile and much time was spent in trying to convene an 
ethics seminar during a large (fertility) unit’s weekly meeting but this did not succeed.  
   
Plans for the content also gradually changed. An emphasis on general ethical principles altered 
into a context specific agenda based on participants’ stated concerns during their interviews. 
From believing that the ethicist should teach and offer `chunks of expertise’  to the group, we 
came to think that she should mainly be a facilitator, encouraging, clarifying and occasionally 
extending the discussion. This slightly reduced our anxiety about how the groups would work, by 
transferring the responsibilities we had assumed were ours (to inform, entertain and enlighten 
without being patronising or too complex or too superficial) towards a sense of more equally 
shared responsibility. The quality of group discussion came to depend on everyone present, when 
it was unhelpful for a few people to work too hard. The main responsibility, however, still rested 
heavily on the ethicist with the added challenge of responding to participants’ initiatives instead 
of providing a preplanned session. We aimed to `bring ethics into the hospital’, physically by 
basing seminars within units, and substantively by involving people with similar expressed 
concerns and  concentrating on their themes. The seminars thus differed from the more usual 
format of the analysis of abstracted cases by generic groups of strangers in ethics centres.  
   
Changes in our plans are illustrated by a) an earlier note, b) the informal agenda decided on the 
day of the first group, and the following section which reports the actual meetings. 
 
[Delete this and instead just put two of Bobbie’s pre-meeting notes of topics?] 
 
a) Plans for possible discussion topics, three weeks before the first group: 
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*  informed choice and autonomy  
*  how do they see increases in prenatal screening affecting their work 
*  prevention of disability and aims to increase the healthy birth rate 
*  possible impact on society of shifts in thinking about who should be born 
*  the invisibility of genetics so far in much clinical practice and policy plans 
*  is there is a surprising gap between emphases on genetics in clinical journals and conferences 
versus daily practice 
*  the being and the becoming of genetics. 
And practical themes such as: 
*  working as a team and relationships between departments, cross-currents,   
    interconnections between professions 
*  creating harmonious team work to benefit patient care 
*  managing change and transition - over past few years with development of scanning 
And evaluation:  
*  what did you gain from the group 
*  how we might improve the format for future groups.  
 
B) Planned agenda on the day of the first group 
(add one or two of Bobbie’s short pre-meeting lists here?)  
 
On the day 
Participants were given a sheet (table x) when they were invited and again when they arrived. We 
arrived in plenty of time to arrange the room, put a notice on the door `research ethics seminar, 
please do not disturb’ remove spare chairs, and arrange chairs for people to be comfortably close 
but not cramped. We served sandwiches and hot drinks, people chatted as they arrived and waited 
for late comers. Participants sat on easy chairs around a coffee table. At the one group which met 
around a large desk level table, people seemed more anxious, less willing to start talking, they 
avoided eye contact and took notes at first. As the participants said later, it took time to warm up; 
other groups more quickly established lively and informal interactions.  
   
Sessions began with informal introductions. Then the ethicist spoke quite slowly for a few 
moments, repeating points on the information sheet described above. She added, 
  
`We all want to talk together and interact, and I will begin with a warning that in a 
philosophically led discussion it is polite to challenge, and you mustn’t feel I’m being 
aggressive if I say Why? Or, How do you back that up? That’s what we’re interested in 
doing, digging out the reasons why you hold your views. Now of course, tell me to get 
lost if you find I’m digging too deep. But please don’t feel uncomfortable, and I think it’s 
quite valid for you to ask each other these sorts of questions, as long as we realise that 
we’ve got to expect each other’s very different views. I’d like to assure you of the 
confidentiality, that we have mentioned. You will not be directly discussed or identified 
when the transcripts are made and reports are written. Does anyone have any procedural 
questions before we begin? I’m afraid I’ll have to rely on you to jump in to the 
discussion, and please don’t feel you are being tested. There are no right or wrong 
answers, it is your own views that matter. We are every interested in the views and 
reasons you have.’  
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The slightly informal language and leisurely pace seemed to encourage most people to speak 
confidently. They listened carefully and seldom interrupted, they often spoke at some length. No 
one was asked to speak unless they looked as if they wished to, so that some people spoke much 
more than others, and a few people hardly spoke, these tended to be non-clinicians. 
 
Within a few days, everyone was telephoned, or occasionally met,  (by CW) to ask them for their 
evaluations of the seminar. The responses are reported in the attached paper: `Examining 
ethics in practice: health service professionals’ evaluations of 
in-hospital ethics seminars’. 
 
Our dilemmas when organising the seminars  
The participants frequently discussed `where to draw the line’ 
between applying new clinical techniques, or else withholding 
them as potentially harmful and unethical. They debated how far 
they should be non-directive and respect patients’ decisions non-
judgementally or else refuse to support decisions they felt to be 
unethical, such as termination for sex selection or for a very 
minor anomaly. They wondered how to provide an equal service for 
varying kinds of people. Similarly, we were sometimes uncertain 
where to draw the line between: collecting research evidence 
while intervening to teach bioethics; documenting people’s views 
and values while also possibly extending and altering these; 
offering a safe space to encourage free discussion yet ensuring 
stimulating relevant debate; probing, questioning and sometimes 
challenging their views without intimidating or silencing people. 
We also pondered on non-directiveness and how to avoid either 
preaching ethical standards or appearing to endorse relativist or 
unethical views if these were expressed. We aimed for equality, 
setting neither too high nor too low an academic level of 
discussion between people with widely differing backgrounds. 
 
Data analysis and writing of papers 
With consent, the 70 interviews and 11 seminars were fully transcribed and were analysed with 
background notes of observations, the relevant literature, press cuttings and other material. 
Transcripts were coded by the researchers individually using methods of open coding and 
grounded theory which allow themes and concepts to emerge from the data.(7) The research team 
met frequently to analyse the data, combining sociological and ethical perspectives to enrich and 
validate the analysis, and sharing work on planning, structuring and revising each paper. For a list 
of completed papers see page xx. 
.  
 
Our experiences of multi-disciplinary research 
 
Besides involving participants from a range of disciplines, the research team combined sociology 
and philosophy. We found this mix valuable and stimulating and record here a few our 
experiences. The two sociologists, Clare and Priscilla, had many  initial concerns about whether 
busy practitioners would agree to give us time and, especially, meet for the ethics seminars. The 
philosopher, Bobbie, was confident that they would be interested in taking part, and was proved 
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right. At first we were anxious about how to explain the new research approaches to potential 
participants. We were unsure what to expect ourselves of the seminars, and therefore how to 
provide adequate information to ensure that the practitioners’ consent was reasonably informed. 
Particularly when inviting people to the first group, it was hard to give them any idea as to what it 
would be like.  
  As the convenor, Clare felt very responsible for the groups: firstly, to her colleagues in getting 
people to attend, because the groups were a key part of the project; secondly, to practitioners 
themselves. With her background as a health practitioner, Clare wondered whether they would 
find the groups useful, and whether busy practitioners would be willing or able to give up around 
two hours of their time, to something that might sound a bit nebulous to them. We wondered 
whether enough people would attend to make a discussion possible, given that the workload of 
many practitioners was heavy and often unpredictable. We were uncertain whether sufficient 
people with nonmedical backgrounds would agree to attend and help to ensure that a range of 
disciplines was involved.    
  Clare wondered if Bobbie would be able to make the groups relevant for all participants, given 
the diversity of their interests. Clare and Priscilla felt nervous as people arrived, trying to 
remember all their names to be able to introduce them to each other. It was a bit like being a party 
hostess, something we've never been good at! Another challenge was to make sure that the 
environment was reasonable - the seminar rooms were either too hot or too cold, one was too  
noisy, and people came in to use the photocopier despite our `please do not disturb - ethics 
research seminar in progress’ notice on the door. One room was rather cramped and stuffy, and 
another too large. Fortunately, participants appeared to become absorbed in the discussions 
quickly, and to ignore the conditions. 
  As the project proceeded, we became more aware that we had all gone into the discussions with 
different agendas and assumptions about what they would and should be like, which we had 
never really discussed. Priscilla said that she had anticipated more challenging and 'consciousness 
raising' discussions. Clare and Bobbie felt that it was vital to treat the participants and their views 
respectfully, and to provide a safe non-judgemental space for them to talk freely and confidently. 
This approach was also valuable for collecting material on practitioners’ frankly expressed views 
to add to the interview data. Most people only attended one seminar, and for many this was an 
introduction to ethics, so that establishing mutual trust and respect were crucial tasks for these 
initial sessions. 
  The sociologists were very pleased and relieved after the first group, to see how skilled Bobbie 
was at facilitation, making everyone feel welcomed and included, and making the discussion 
relevant. Although we had faith in Bobbie, Clare’s experience at a recent conference, which was 
her first meeting en masse with ethicists, had left her anxious. Many of them seemed to be not 
really in touch with the realities of  health care and were more keen to score points in terms of 
how well they argued, rather than  thinking about the people represented by the case studies they 
were discussing with small groups. 
  Clare found pleasure at doing the follow up interviews, and hearing how much people felt that 
they'd gained from the groups, and sharing their reports with the research team. She also became 
interested in the points that Bobbie picked up on, and others that she let go. One of these points  - 
that the value of the fetus for some practitioners becomes the value that the pregnant woman 
places on it -  became the basis of a joint paper. 
  While working on the end-of-project presentations to give at both the hospitals, we were 
concerned to make the research reports relevant for all concerned. We expected practitioners to 
want mainly practical recommendations for improving the services they provide, and we debated 
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how to present research findings which stress difficulties, complications and ambiguities in their 
work which do not have easy solutions. 
  Priscilla found the monthly team meetings, and almost daily discussions while analysing data 
and writing papers, especially valuable. They helped to draw out ideas which otherwise would 
have remained much less developed. Writing joint papers was very enjoyable, and it shared out 
the tasks and burdens. For each paper, the lead writer did most of the drafting, sifting through the 
data, selecting and editing quotations, and setting out the themes and commentaries. The other 
two were then able to make major and minor editing suggestions, and could see the paper with a 
more detached clarity than if they had written the first stage. We usually agreed with one 
another’s suggestions. Clare was meticulous in checking that the transcriptions and the edited 
quotations were accurate and did justice to the original speakers.  
  Another useful exercise was when all three of us wrote `what genetics means to me’. We 
discussed our very varied replies and this alerted us not to expect standard responses during the 
interviews and to be aware of how complex and tentative notions about genetics can be.         
  Generally, we all held feminist views about women’s rights to choose to terminate a pregnancy. 
Clare was particularly interested in unravelling the many difficulties which the women and 
practitioners faced when trying to ensure informed choice. Bobbie added philosophical theories 
about respect for women’s autonomy and rights, and whether the fetus counts in any sense as a 
person with rights. The philosophy was woven into the discussions during the seminars and 
during the data analysis and writing of papers, especially about varying concepts of the value of 
the fetus. Priscilla started from a position which was trying to combine feminist and 
philosophical traditions with respect for disabled people, as some disability writers (such as 
Shakespeare, 1999) advocate. We had challenging discussions which helped Priscilla to complete 
two papers on screening for Down’s syndrome begun during a previous European project 
(Alderson, in press, a and b). Our views altered during the project, illustrating the benefits of 
multidisciplinary research, as we were influenced by and developed an appreciation of each 
others’ views, and the backgrounds that we were drawing on. Our understanding of the disability 
rights perspective is one example, and this especially developed during the co-drafting of papers, 
commenting on them, and agreeing on the final versions. These were times when differences 
particularly emerged, new understandings of each others’ views were reached, and compromises 
were made, so that we were all (reasonably) happy with the final version that was submitted. 
  Bobbie had always wanted to get involved in empirical research, and in the past had been 
frustrated by the abstract and detached nature of much philosophising. Even applied ethics can 
seem divorced from reality at times. In all her work Bobbie’s aim is to talk to people who have 
the power to make a difference, not to other philosophers who care only about the elegance of 
arguments. This project therefore combined two things she values, talking to health care 
professionals about what they do, and helping them to sort out what they ought to do, and 
secondly, finding out whether the preoccupations of philosophers in any way reflect the concerns 
of those involved in health care. She thought that the project allowed her to learn so much about 
how research is done, and saw it as an apprenticeship which is still ongoing. She felt very much 
the junior partner, yet felt confident to have a view and have a go. She valued the sociologists’ 
endorsement of her methods of facilitating the groups. At times it was not possible to combine 
providing a supportive introduction to ethics, with challenging controversial and occasionally 
discriminatory views expressed by some participants. Encouraging people to speak sometimes 
involved the risk of seeming implicitly to endorse these views. With many participants, however, 
we had only one meeting in which to try to achieve aims which sometimes conflicted, and we had 
to temper our approach in the light of this limitation. Had we had the chance to meet, say, over a 
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period of six weeks, Bobbie thought that we could have discussed controversies much more 
deeply, and that participants who stayed the course would have relished the challenge. At the 
initial meetings we succeeded in being inclusive, safe and gently questioning. 
  Bobbie considered that we have learnt that co-researchers need to spend more time at the 
beginning of a project sharing their perspectives, goals and priorities. She valued the discussions 
we had on respecting the research participants’ confidentiality, and in how challenging we should 
aim to be. If we had discussed and resolved these questions earlier in the research process, we 
might have avoided some tensions during the group sessions.  
  Philosophers work in a very different way to sociologists, Bobbie now believes, and speed of 
response to the data is an example of this. A philosopher is used to the luxury of thinking time 
and slow reflection, in fact these are the only 'laboratory tools' philosophers require. She will 
probably be reflecting on this project for several years to come and producing papers borne of it 
for longer whereas sociologists, because of the way their work is organised, are not allowed this 
longer gaze, but maybe do not want it. 
  The project built research capacity by considerably increasing our appreciation of one another’s 
disciplines and of the rewards of working together. We also gained understanding of how 
combining philosophy and sociology can enrich the gathering, analysis and reporting of the 
research data, besides the linking of evidence to insights into current and future policy and 
practice concerning genetics in clinical care.  
 
Confidentiality 
We put much time into discussing the issue of confidentiality, and sometimes had to make 
compromises. In order to include a diverse group of practitioners, we had often only interviewed 
one or two representatives from each specialty. Some of these were people doing fairly unique 
jobs, which would make them easy to identify. When writing, we therefore agreed to use 
umbrella terms, such as 'obstetrician', to represent not only obstetricians, but also those working 
in fetal medicine, both senior and junior doctors, but to allocate individual numbers to each 
participant. This caused problems when writing papers, when, for example, those whom we had 
similarly labelled with the umbrella term midwife, but who were actually senior managers, were 
quoted. Sometimes it was obvious from the quote that the midwife speaking was a senior 
manager, and at other times the quote might be more informative for readers if it was known that 
the remark had been made by a senior manager. However, such senior managers might be 
recognised, as they are few in number. For this reason, we  gave a few easily identifiable 
participants two numbers and two job titles.  
 
5.  Results  (is this the right heading?)  Combine with  
6.   Conclusions and implications of the research 
[To many readers this will be the most important section. Can we 
discuss on Monday?]  
 
Meeting the research aims   
According to the participants’ evaluations, the seminars met the 
research aims, noted earlier. Almost everyone found the seminars 
useful in assisting team discussion by regrouping staff in new 
ways, drawing on their very varied expertise, and encouraging 
them to learn from one another and to address crucial but seldom 
discussed topics. The groups worked well in two different types 
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of hospital (teaching and district) and across a range of 
specialties. The seminars were academically sound, in that people 
at all levels of knowledge and experience said they were 
interested and informed, including people qualified in ethics and 
those new to the subject. The title of `ethics’ warranted wide-
ranging discussions from health policies, science and society, to 
professional practice and relationships, knowledge, thoughts and 
feelings. As many people mentioned, these were welded into 
coherent discussions. The sessions appeared to avoid being too 
obvious, superficial, complicated, theoretical or remote from 
practice.    
 
The seminars contributed to the larger research project, when the 
staff were both research subjects and partners, contributing 
data, gaining and generating new insights through their 
interactions, and controlling how much they wished to be 
involved. The sessions offered time and space for sharing seldom 
talked about concerns, and for expanding people’s thinking about 
ethics. The seminars documented how the health professionals’ 
views about social and ethical consequences of advances in 
genetics and their impact on professional policies and practice, 
expressed during earlier individual interviews, were repeated or 
modified, confirmed, developed or challenged by their colleagues. 
The groups therefore partly validated the interview data showing 
where there was broad agreement. The evaluations and other data 
illustrated interactions between disciplines with different aims, 
methods and values.   
 
Evidence, analysis and publications (8 April 2001 rough notes for 
discussion follow here) 
Maybe we need a section here about how our papers met the 
research aims  
and I think we need sections on:  
Might we summarise main conclusions from each paper, whoever was 
lead author? 
Limits to reviewing social and ethical consequences  - though we 
could summarise quite a bit on this 
 
Practical recommendations for future seminars  
*  Preliminary interviews were vital, in order to base the 
seminars on key local, practical concerns to the staff.  
*  It is likely that instead of a visiting ethicist, an in-
hospital part-time ethicist who routinely spends time observing 
and talking with staff, planning sessions with them and following 
up their concerns would be more useful. A Trust appointment would 
overcome the problems mentioned about confidentiality.    
*  Ethics moved geographically into the hospitals and also 
substantively into practitioners’ daily concerns. It was 
important to avoid general and abstract ethical discussions. 
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This, and the way groups attended in-hospital seminars, appears 
to have stimulated more debate with other colleagues later, and 
attracted people new to ethics to attend, than when one or two 
people attend external courses. 
*  Care taken in arranging the right number of chairs in a close 
circle and welcoming people helped to create a pleasant 
atmosphere. A midwife commented `The ambiance was good. I liked 
the way you welcomed everyone personally and had hot drinks and 
food, it was done in a leisurely way, around a coffee table, I 
didn’t feel pressured at all.’     
*  The effects are likely to be more useful and lasting from a 
series of seminars which develop people’s confidence, insights 
and critical debate. The series should encourage wide-ranging 
debate but also have specific topics and aims planned with the 
participants in order to avoid repetition. The place and timing 
of sessions and the mix across disciplines and hierarchies would 
require careful discussion.  
* The costs of preparing and organising the meetings, 
refreshments, the ethicist’s and participants’ time would need to 
be covered. A dedicated, patient, persistent and tactful person 
would be needed to set up the sessions.       
 
Ethics - to consider critical questions or to assist smooth 
progress? 
I think we should emphasise the dangers of rushing into action 
without due reflection the ethics which helps things to proceed more smoothly or the 
ethics of holding back, questioning policies and making space to think and rethink them. Also 
the need for making connections between different professional 
perspectives, and across hierarchies, such as the experience of 
daily work with pregnant women linked to local and national 
policy making awareness of the micro in the macro context   the 
place of academic research to increase insight which 
practitioners and policy makers can use apply in their work it is 
not our place to make practical recommendations but to show 
people (what they often already know) perhaps a little more 
clearly and illuminated by drawing different insights together 
which busy practitioners may not have time or opportunity to do.  
   
They have told us their views and experiences we have relied on 
their knowledge   but we have had time to listen at some length 
to a wide range of people some of whom seldom meet during 
seminars some participants expressed surprise or relief at 
learning that others shared their views. 
   
There was a breaking of silence, permission to share seldom 
expressed concerns. Just as practitioners find they have to 
little time to discuss the questions with women in prenatal 
clinics and that the women tend to have to make decisions based 
  27 
on too little information and a sense of private anxiety and 
individual responsibility for their dilemmas, so the 
practitioners appear to feel under informed and privately 
carrying duties and being potentially culpable instead of being 
able to recognise that they stem from public and economic 
policies.    
     
The difficulty of looking below the surface, at what may appear 
obvious once it is described but which is often missed, 
especially perhaps in invisible elusive matters of values and 
ethics,  is illustrated by a review of a book by four 
distinguished ethicists. Noah Efron (who works in an Israeli University and is 
writing Golem, God and Man: on biotechnology) reviewed From chance to choice: genetics and 
justice,  by Buchanan A, Brock D,  Daniels N, and Wikler D 2000 Cambridge University Press). 
He praised the power and detail of their arguments but showed 
that they missed key issues. He summarised the book as considering ethical 
dilemmas in relations between scientists and society, and between governments and individuals. 
The four authors argue that these ethical dilemmas concern justice more than freedom, in the fair 
distribution and sharing out of the benefits of new genetic technologies. They follow Rawls’s 
questioning of how we can create a just society despite the natural differences between people, 
for example, of ability or opportunity. Like Rawls they conclude that people are willing to accept 
inequality if goods are shown to benefit the least well off members as much as the most well off  
ones. They conclude by advocating human genetic modification as a means to increasing 
equality, fairness and autonomy. But, Efron asks, but how can we ensure equality, fairness and 
autonomy when these concepts can no longer be fixed or agreed because the genetic technologies 
alter not just what we have, but who we are and thus our normative concepts and values, identity 
and relationships. Similarly we have aimed to bring to the surface 
seldom discussed views and values as well as reviewing present 
developments in the light of possible futures while seeking to 
avoid making unfounded predictions.  
 
Examining the future (still repetitive here) 
Tables 1-3 show how rapidly new genetic knowledge and techniques 
were advancing, so that social research on these issues can 
quickly become out of date, a historical record instead of 
offering means of understanding and addressing social and ethical 
questions raised by future developments before they quickly 
become present realities. We asked  the health care staff about 
their views of the past, present and future, how they felt they 
were, and would be, affected by genetic advances. We traced how, 
and possibly why, quite tenuous new ideas and under-evaluated 
technologies can so rapidly pervade the health services over the 
past three decades, such as genetic counselling, prenatal 
screening and scanning and the increasing application of genetics 
in the preconception and paediatric services. 
 
In areas of very rapid change, sociologists are posed with the problem of how to avoid writing 
history - records and analysis which have been superseded by events before their reports are 
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published. Our research about contemporary topics suffers the added disadvantage of lacking 
historical foresight/hindsight. How can our research inform or warn if it is confined to solid 
evidence which so rapidly becomes defunct? And yet the problems of speculating rationally 
about likely futures seem equally severe. Barbara Adam’s foreword to Contested futures (8) notes 
that ` the techno-science of today creates future presents for our successors’ who cannot influence 
today’s decisions. `It is [therefore] the socio-political task of the present’ to research future as 
well as current needs. She advises that sociologists can explain and render visible present taken-
for-granted and often ignored processes, by examining how the future is created, contested and 
managed; how opportunities are created for some at the expense of others; how uncertainties and 
contingencies are handled and risks and benefits are balanced. The task is not to predict the future 
but to identify intricate interactions and the use of language and metaphors which rewrite the 
present into the future as, for example, in the use of religious terms and imagery. 
 
Paving the way to genetics 
The cross currents in genetics and ethics research project 1999-2001 was initially designed to 
examine the influence of genetics in preconceptual services. The department we approached in 
1998, however, felt that genetics was not a relevant enough issue to be worth researching in 
preconceptual services. In contrast, consultants working in general obstetrics and fetal medicine 
welcomed and supported the research plans. Currently the main practical impact of genetic 
knowledge is in prenatal detection of fetal abnormalities in order to offer prospective parents the 
option of termination of pregnancy. Our research was therefore conducted mainly in the prenatal 
services, and expanded into neonatal, community paediatrics and haematology services in the two 
hospitals.  
 
[I’ve left this bit in because I wonder if we can do something with this idea? Social research 
therefore risks becoming simply a historical record, instead offering means of understanding and 
addressing social and ethical questions raised by future genetic developments before they quickly 
become present realities.  
  This possible paper would report ideas propounded in our research interviews and seminars, and 
set them in the context of contemporary research literature and media reports and speculation. 
The paper covers past, present and future in its aims: (1) to indicate how health care practitioners 
and mangers believed they were being and soon would be influenced by new genetic knowledge 
and techniques at the millennium; (2) to compare their views with those of researchers, policy 
makers and journalists; (3) to trace how and possibly why quite tenuous new ideas and under-
evaluated techniques can so rapidly penetrate the health services. These innovations, some over 
the past three decades, others through recent rapid expansion, include genetic counselling, 
prenatal screening and scanning, and the increasing application of genetics in the preconception 
and paediatric services.] 
 
The language of certainty or of probability 
We examined how medical and genetic information is presented and managed to serve certain 
aims and interests. One example is the phrase `Down’s syndrome is the commonest form of 
severe mental retardation’, which frequently appears on clinic leaflets and is mentioned by staff. 
Firstly, `mental retardation’ is now a criticised term in some circles and certain British journals 
ask authors to replace it with ` severe learning difficulties’. The changes of terminology from fool 
to idiot to feeble minded to retarded to learning difficulties denotes discomfort not only about the 
disability itself, but also about the unfortunate history of medical management (ref). `Learning 
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difficulties’ is the phrase preferred by people who have these difficulties (ref), partly because it 
indicates an educational rather than a medical problem, one that is treatable and not, as medical 
authors conclude, untreatable,(ref) and one which everyone shares to some extent across the 
whole spectrum of humanity. It is a more inclusive term. `Mental retardation’ is likely to sound 
more alarming to expectant parents. `Learning difficulties’ is also an appropriately contextual 
term; people have difficulties in some contexts and not in others. Learning difficulties are 
constructed or exacerbated when people are treated as much less able than they could be, and are 
excluded from opportunities to learn through self-fulfilling negative expectations.   
 
The second aspect of the phrase which biases the information negatively is in the words `the 
commonest form’. `The commonest diagnosed form’ would be more accurate. Approximately 
one in 100 people have severe learning difficulties (SLD) and approximately one in 600 people 
have Down’s syndrome. Five in 100 people with SLD therefore have some other condition from 
a wide range of conditions, many of which remain undiagnosed. The third negative complication 
is in the implicit certainty of the phrase, which glides over controversies about whether IQ, and 
therefore SLD, can be defined or assessed, and about the social construction of disability (ref). 
For example, health professional tend to speak of ` some children with Down’s syndrome are able 
to attend mainstream schools, but very few of them’, as if the school attended accurately reflects 
the assessed IQ of the child. Yet there is little correlation. Instead, choice of school depends on 
available places and this depends on provision and policies of local education authorities (LEA). 
Some LEAs admit all local children with Down’s syndrome to comprehensive mainstream 
schools, others send all of them to SLD schools, others have a range of options.  
 
The `fight’ with the LEAs which many parents have over the choice of their child’s school 
illustrates how the choice depends more on beliefs about SLD than on they type of precise 
medial-psychological IQ assessment which is implied by infomration in the prenatal clinic. A 
leaflet given out by the clinic states: `Down’s syndrome is the most common cause of mental 
handicap and it occurs in about 1 in 700 pregnancies.’The implicit certainty and precision in 
these few words illustrate how, on a far wider scale, many kinds of tentative, ambiguous concepts 
are repackaged into authoritative medical certainties. Pressures such as time constraints, health 
professionals’ training, textbook knowledge, and traditional ways of giving information and 
invoking trust, all undermine efforts to transfer from explaining certainties to explaining 
probabilities. Yet this transfer is essential if the clinic staff and perspective parents are to be able 
to have informed discussions about, for example, the probabilities in maternal serum screening 
results, or the prognosis of a fetal condition. 
 
Although the staff implemented policies which, without the professionals’ agency would remain 
unfulfilled, they tended to deny their own agency and to transfer power onto other agents or 
structures. Practitioners and also managers frequently alluded to commercial, consumerist and 
media pressures on them, and their need to manage risk, prevent litigation, and accept economies 
in their resources. The pressures on the staff to offer an equal standardised service raised three 
great difficulties for them: equity - to attempt to offer a fair service to all no matter how unequal 
the patients were in their needs or abilities; sensitivity - to provide a flexible, reasonably tailored 
and humanely responsive service, within the framework of impersonal, standardised equality; 
professional ethics - is this a code of binding principles which guide practitioners’ and patients’ 
decisions, or should the non-judgmental expert promotes health through respecting patients’ 
choices? The paradoxical concept of respect for autonomy, as either a principled imperative or 
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relativist licence, encapsulates the professionals’ dilemma, which we address in our papers for 
publication.   
 
Cross currents in genetics 
Each profession plays varying parts in how they initiate or lead, 
support, accept or r resist innovations. The interviewees tended 
to assume that their profession must be drawn in to support 
prenatal screening and testing programmes. The clergy, even a 
Roman Catholic chaplain, and the various counsellors spoke of 
supporting distressed parents after termination of pregnancy 
`picking up the pieces’ helping people to `go through the 
grieving process’ without blaming them in any way. The 
counsellors who combined psychological support and listening with 
giving information would advise, for example, parents to agree to 
an autopsy in order to gain some relief through knowing about the 
cause of a stillbirth and to gain some confidence and hope about 
the informed care during future pregnancies. In these ways they 
presented genetics as valuable knowledge which answers society’s needs. For  psychologists and 
psychiatrists, genetics might provide scientific evidence to support diagnoses of behaviours for 
which they currently have to rely on symptoms alone, and not on definitive signs such as 
genotypes. Ethicists and theologians have shown how their specialised knowledge can 
complement genetic knowledge and research - such as in the ethics of individual autonomy which 
fits the `selfish gene’ ethos, or in a classical history of gynaecology from Aristotle and Aquinas 
which removes objections to embryo research.  
 
 The midwives, individually and collectively through their Royal 
College, appear to accept the growing list of risks to discuss 
with pregnant women, apart from complaining about lack of time 
and the difficulty of helping women to understand the 
information. Midwives describe rising aspirations, from 
delivering a living baby to achieving a `perfect’ baby These professions-
related-to-medicine followed the medical lead and played 
supportive `handmaiden’ roles, which maintained and strengthened 
their own positions in multidisciplinary teams. They could be 
seen as more professional in dealing with scientific, up-to-date 
genetic knowledge, in some cases at the leading edge of research 
and innovative practice. [Haematology staff rather different knew 
it increased complexity and skill.] 
 
Among doctors themselves, the community paediatricians were 
surrounded by expert parents, psychologies, special teachers and therapists and they cared for 
children with sometimes undiagnosed and seemingly untreatable, incurable conditions. The team 
members all spent time advising parents on the daily care of disable children and in practical 
matters the doctors did not necessarily have greater knowledge. Genetic knowledge promised to 
enable the doctors to make new, unique contributions to managing the children’s conditions, 
which would thus distinguish them more clearly from other members of their multi-disciplinary 
teams. The doctors valued medicine’s scientific and moral obligation to clarify, whenever 
possible, diagnoses, prognoses, decisions about treatment and information to patients and carers 
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through understanding of the cause and nature of disease. Genomics offers exceptionally clear 
forms of understanding, rigour and accuracy in diagnosis. It is far less clear on prognosis, and the 
haematology staff were very aware of these complexities. We are analysing the transcripts which 
show how the various professions reacted and interacted in their responses to genetic 
developments.   
 
7.  Future research priorities - outstanding questions 
Our research has identified great ambivalence, some enthusiasm 
and some anxiety about established and newer techniques, 
including prenatal screening and genetic diagnosis, among the 
health professionals whom we interviewed. Continuing research 
about their explicitly held views and the underlying structures 
which influence their daily practice and policy making is needed 
in order to increase understanding of the effects and efficiency 
of their work.  
 
Similar qualitative research with parents who use these services, 
to complement the mainly quantitative psycho-metric research 
which has been conducted so far, would also provide important 
missing infomration.  
 
In view of the profound concerns raised during the in-hospital 
ethics seminars, and the participants’ general views on their 
value in discussing important but neglected questions, we 
conclude that the seminars are a useful format for hospital 
Trusts to develop. These are likely to be especially useful in 
areas of change, such as is beginning to occur through new 
genetics knowledge. The groups could also be useful in risk 
management and clinical governance.  
 
Although this short study of single-event seminars cannot 
estimate the impact on participants’ practice or policy making, 
it does provide a promising start towards multi-disciplinary ways 
of addressing dilemmas in everyday health care. The main evidence 
lies in the interest and need expressed by participants for the 
seminars, and a few reported effects on practice. It remains to 
be seen how well the seminars would work with other ethicists and 
in various clinical specialties. Seminars might fit into routine 
department meetings. However, professional and public awareness 
of the relevant ethical questions and how these can serve more 
informed debate and decision making would be increased through 
greater use of the ethics seminar format we have developed, 
complemented by prior sociological interviews to elicit 
participants’ key concerns. 
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